Project
Athena-SSc-ILD-Study
Automatically Closed ยท 2022 until 2024
Peischl Riana, Peischl Shirin, Bartz-Batliner Mira, Hutz Carina Liane, Rubbert-Roth Andrea, Schmiedeberg Kristin
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2022
End Date
2024
Financing
Others
Phase
II
Brief description/objective
A double blind, randomized, placebo-controlled study to evaluate the efficacy and safety of PRA023 in Subject with Systemic Sclerosis associated with interstitial Lung Disease.